
| 2019 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
Total number of projects: 3
As coordinator: 1
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0.5*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2022 | 2.988.435 | 0 | 1.003.250 | 1 | ||
| 2021 | 0 | 887.800 | 0 | 1 | ||
| 2019 | 0 | 4.066.231 | 280.806 | 1 | ||
Total number of partners: 37
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 37
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2022-03-01 | NATURAL INTRAOCULAR PHOTOACTIVATION OF COMPOUNDS TO FIGHT RETINOPATHIES | NeoVasculoStop | coordinator | 2.988.435 | 6 |
| 2021-01-01 | Commercial & Research Opportunity for Cysteinyl Leukotriene Signalling in Ocular & CNS Dysfunction, Cancer and Cardiovascular Disease | CRYSTAL3 | participant | 887.800 | 12 |
| 2019-09-01 | Ocular Research By Integrated Training And Learning | ORBITAL | participant | 4.066.231 | 22 |